acetylgalactosamine has been researched along with Diabetes Mellitus, Type 1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brünggel, K; Damo, M; Diaceri, G; Hirosue, S; Hubbell, JA; Quaglia-Thermes, X; Raczy, MM; Wilson, DS | 1 |
1 other study(ies) available for acetylgalactosamine and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes.
Topics: Acetylgalactosamine; Acetylglucosamine; Adoptive Transfer; Animals; Antigen Presentation; Autoantigens; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Immune Tolerance; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Spleen; T-Lymphocytes | 2019 |